TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Terragen Holdings Ltd ( (AU:TGH) ) just unveiled an update.
Terragen Holdings Limited has been granted a US patent for its microbial feed supplement, Terragen Probiotic for Ruminants™ and MYLO®, by the United States Patent and Trademark Office. This patent, valid until 2041, provides intellectual property protection in the US, a key market for Terragen, and supports the company’s efforts to secure regulatory approvals for product launch. The patent strengthens Terragen’s position in the global animal probiotics market, highlighting the innovative outcomes of its research and development program.
More about Terragen Holdings Ltd
Terragen Holdings Limited is an Australian company specializing in the development of biological products aimed at improving animal and plant health for agricultural use. Their product range includes animal probiotics like MYLO® and Terragen Probiotic for Ruminants™, which enhance livestock growth and reduce methane emissions, as well as a plant bio-stimulant called Great Land Plus® that boosts crop yields and reduces reliance on chemical fertilizers.
Average Trading Volume: 277,847
Technical Sentiment Signal: Sell
Current Market Cap: A$9.6M
For detailed information about TGH stock, go to TipRanks’ Stock Analysis page.